Suppr超能文献

高度近视患者准分子原位角膜磨镶术的十年随访

Ten-year follow-up of laser in situ keratomileusis for high myopia.

作者信息

Alió Jorge L, Muftuoglu Orkun, Ortiz Dolores, Pérez-Santonja Juan Jose, Artola Alberto, Ayala Maria Jose, Garcia Maria Jose, de Luna Gracia Castro

机构信息

Vissum-Instituto Oftalmológico de Alicante and Division of Ophthalmology, Miguel Hernandez University, Medical School, Alicante, Spain.

出版信息

Am J Ophthalmol. 2008 Jan;145(1):55-64. doi: 10.1016/j.ajo.2007.08.035. Epub 2007 Nov 8.

Abstract

PURPOSE

To evaluate the long-term outcomes of laser in situ keratomileusis (LASIK) for high myopia.

DESIGN

A long-term (10 years) follow-up retrospective interventional case series study.

METHODS

The study included 196 myopic eyes of 118 patients with a mean preoperative spherical equivalent of -13.95 +/- 2.79 diopter (D) treated with myopic LASIK at the Instituto Oftalmológico de Alicante, Spain using the VISX 20/20 excimer laser (VISX Inc, Santa Monica, California, USA) and the Automated Corneal Shaper microkeratome (Chiron Vision, Irvine, California, USA). All patients were evaluated three months, one year, two years, five years, and 10 years postoperatively. The main outcome measures were refractive predictability and stability, mean corneal keratometry, topographical cylinder, safety, efficacy, stability of visual acuity, and postoperative complications.

RESULTS

At 10 years, 82 (42%) of 196 eyes were within +/-1.00 D and 119 (61%) were within +/-2.00 D. Fifty-four (27.5%) eyes underwent retreatments attributable to under correction and/or regression. The myopic regression decreases with time in eyes that did not undergo retreatment with a mean rate of -0.25 +/- 0.18 D per year. Eleven eyes (5%) lost more than 2 lines of best spectacle-corrected visual acuity (BSCVA) and 78 eyes (40%) showed a postoperatively uncorrected visual acuity of 20/40 or better. Two eyes (1%) with more than 15 D myopic correction developed corneal ectasia.

CONCLUSIONS

LASIK for myopia over -10 D is a safe procedure with myopic regression that slows down with time and a high rate of BSCVA increase in the long-term.

摘要

目的

评估准分子原位角膜磨镶术(LASIK)治疗高度近视的长期疗效。

设计

一项长期(10年)随访的回顾性干预性病例系列研究。

方法

该研究纳入了西班牙阿利坎特眼科研究所118例患者的196只近视眼睛,术前平均等效球镜度数为-13.95±2.79屈光度(D),使用VISX 20/20准分子激光(VISX公司,美国加利福尼亚州圣莫尼卡)和自动角膜板层刀(Chiron Vision公司,美国加利福尼亚州欧文)进行近视LASIK手术。所有患者在术后3个月、1年、2年、5年和10年进行评估。主要观察指标为屈光预测性和稳定性、平均角膜曲率、地形图柱镜、安全性、有效性、视力稳定性及术后并发症。

结果

10年后,196只眼中有82只(42%)在±1.00 D范围内,119只(61%)在±2.00 D范围内。54只(27.5%)眼睛因欠矫和/或回退而接受了再次治疗。未接受再次治疗的眼睛近视回退随时间减少,平均每年-0.25±0.18 D。11只眼睛(5%)最佳矫正视力(BSCVA)下降超过2行,78只眼睛(40%)术后裸眼视力达到20/40或更好。2只近视矫正超过15 D的眼睛(1%)发生了角膜扩张。

结论

LASIK治疗超过-10 D的近视是一种安全的手术,近视回退随时间减缓,长期来看BSCVA提高率较高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验